Aesthetic Plastic Surgery

, Volume 35, Issue 6, pp 1079–1086 | Cite as

Treatment of Axillary Hyperhidrosis With Botulinum Toxin: A Single Surgeon’s Experience With 53 Consecutive Patients

  • Melissa A. Doft
  • Jennifer L. Kasten
  • Jeffrey A. Ascherman
Original Article



Axillary hyperhidrosis is a debilitating disease that affects the social and occupational lives of many Americans. It can be treated with subdermal injections of botulinum toxin. This study aimed to determine the interval between injections during which patients are symptom free and whether that interval varies depending on the number of treatments a patient has received.


The study enrolled all the patients treated with botulinum toxin for axillary hyperhidrosis by the senior author between 2004 and 2010. Patient responses to the treatment with regard to both satisfaction and length of the symptom-free interval were collected prospectively and analyzed. An in-depth PubMed search was performed through July 2010 to compile the published data on using botulinum toxin injections to treat axillary hyperhidrosis. These data served as a benchmark to which the trends at our institution were compared.


The 53 patients included in the study had an average age of 29 years, and 64% were women. Of the 53 patients, 23 (43%) underwent multiple injections of botulinum toxin. The average symptom-free interval was 261 days. There was no statistically significant difference in symptom-free intervals after multiple treatments. Patient satisfaction rates were very high, similar to the high degrees of satisfaction found in the published data.


Botulinum toxin injections provide an effective treatment for axillary hyperhidrosis with a rapid onset and high patient satisfaction. Many patients have a symptom-free interval of 6–9 months after each botulinum toxin injection. This interval does not change significantly after multiple treatments.


Axillary hyperhidrosis Botox Botulinum toxin 



We thank Jimmy Duong, MPH, from Columbia University’s Irving Institute and Department of Biostatistics for his assistance in the statistical analysis of our results. There was no funding for this project.

Conflict of interest



  1. 1.
    Strutton DR, Kowalski JW, Glaser DA, Stang PE (2004) U.S. prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 51:241–248PubMedCrossRefGoogle Scholar
  2. 2.
    Naumann MK, Hamm H, Lowe NJ, on behalf of the Botox Hyperhidrosis Clinical Study Group (2002) Effect of botulinum toxin type A on quality-of-life measures in patients with excessive axillary sweating: a randomized controlled trial. Br J Dermatol 147:1218–1226PubMedCrossRefGoogle Scholar
  3. 3.
    Solish N, Benohanian A, Kowalski JW (2005) Prospective open-label study of botulinum toxin type A in patients with primary axillary hyperhidrosis: effects on functional impairment and quality of life. Dermatol Surg 31:405–413PubMedCrossRefGoogle Scholar
  4. 4.
    Swartling C, Naver H, Lindberg M (2001) Botulinum A toxin improves life quality in severe primary focal hyperhidrosis. Eur J Neurol 8:247–252PubMedCrossRefGoogle Scholar
  5. 5.
    Campanati A, Penna L, Guzzo T et al (2003) Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study. Clin Ther 25:298–308PubMedCrossRefGoogle Scholar
  6. 6.
    Hornberger J, Grimes K, Naumann M, Glaser DA, Lowe NJ, Naver H et al (2004) Multi-specialty working group on the recognition, diagnosis, and treatment of primary focal hyperhidrosis: recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol 51:274–286PubMedCrossRefGoogle Scholar
  7. 7.
    Atkins JL, Butler PEM (2002) Hyperhidrosis: a review of current management. Plast Reconstr Surg 110:222–228PubMedCrossRefGoogle Scholar
  8. 8.
    Rompel R, Scholz S (2001) Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis. J Eur Acad Dermatol Venereol 15:207–211PubMedCrossRefGoogle Scholar
  9. 9.
    Flanagan KH, King R, Glaser DA (2008) Botulinum toxin type A versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis. J Drugs Dermatol 7:221–227PubMedGoogle Scholar
  10. 10.
    Zacherl J, Huber ER, Imhof M et al (1998) Long-term results of 630 thoracoscopic sympathicotomies for primary hyperhidrosis: the Vienna experience. Eur J Surg Suppl 580:43–46PubMedGoogle Scholar
  11. 11.
    Lin T, Wang N, Huang L (2001) Pitfalls and complication avoidance associated with transthoracic endoscopic sympathectomy for primary hyperhidrosis (analysis of 2,200 cases). Int J Surg Investig 2:377–385PubMedGoogle Scholar
  12. 12.
    Gossot D, Galetta D, Pascal A et al (2003) Long-term results of endoscopic thoracic sympathectomy for upper limb hyperhidrosis. Ann Thorac Surg 75:1075–1079PubMedCrossRefGoogle Scholar
  13. 13.
    Arneja JS, Hayakawa TEJ, Singh GB et al (2007) Axillary hyperhidrosis: a 5-year review of treatment efficacy and recurrence rates using a new arthroscopic shaver technique. Plast Reconstr Surg 119:562–567PubMedCrossRefGoogle Scholar
  14. 14.
    Tung T (2001) Endoscopic shaver with liposuction for treatment of axillary osmidrosis. Ann Plast Surg 46:400–404PubMedCrossRefGoogle Scholar
  15. 15.
    Bushara KO, Park DM, Jones JC et al (1996) Botulinum toxin: a possible new treatment for axillary hyperhidrosis. Clin Exp Dermatol 21:276–278PubMedCrossRefGoogle Scholar
  16. 16.
    Glogau RG (1998) Botulinum A neurotoxin for axillary hyperhidrosis: no sweat Botox. Dermatol Surg 24:817–819PubMedCrossRefGoogle Scholar
  17. 17.
    Naver H, Swartling C, Aquilonius SM (2000) Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up. Eur J Neurol 7:55–62PubMedCrossRefGoogle Scholar
  18. 18.
    Naumann M, Lowe NJ (2001) Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomized, parallel group, double-blind, placebo-controlled trial. BMJ 323:596–599PubMedCrossRefGoogle Scholar
  19. 19.
    Odderson IR (2002) Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis. Dermatol Surg 28:480–483PubMedCrossRefGoogle Scholar
  20. 20.
    Heckmann M, Ceballos-Baumann AO, Plewig G (2001) Hyperhidrosis Study Group: Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 344:488–493PubMedCrossRefGoogle Scholar
  21. 21.
    Lowe NJ, Glaser DE, Eadie N et al (2007) Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol 56:604–611PubMedCrossRefGoogle Scholar
  22. 22.
    Heckmann M, Plewig G (2005) Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study. Arch Dermatol 141:1255–1259PubMedCrossRefGoogle Scholar
  23. 23.
    Kowalski JW, Eadie N, Daggett S, et al (2004) Validity and Reliability of the Hyperhidrosis Disease Severity Scale (HDSS). Poster presented at the 62nd Annual Meeting of the American Academy of Dermatology, 6–10 February 2004, Washington, DC, Poster P198Google Scholar
  24. 24.
    R Development Core Team (2009) R: a language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria, 2009, ISBN 3-900051-07-0. Accessed June 2010
  25. 25.
    Wollina U, Karamfilov T, Konrad H (2002) High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval. J Am Acad Dermatol 46:536–540PubMedCrossRefGoogle Scholar
  26. 26.
    Naumann M, Lowe NJ, Kumar CR et al (2003) Botulinum toxin type A is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study. Arch Dermatol 139:731–736PubMedCrossRefGoogle Scholar
  27. 27.
    Zuber M, Sebald M, Bathien N et al (1993) Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance. Neurology 43:1715–1718PubMedGoogle Scholar
  28. 28.
    Jankovic J, Schwartz K (1995) Response and immunoresistance to botulinum toxin injections. Neurology 45:1743–1746PubMedGoogle Scholar
  29. 29.
    Moffat CE, Hayes WG, Nyamekye IK (2009) Durability of botulinum toxin treatment for axillary hyperhidrosis. Eur J Vasc Endovasc Surg 38:188–191PubMedCrossRefGoogle Scholar
  30. 30.
    Absar MS, Onwudike M (2008) Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis. Dermatol Surg 34:751–755PubMedCrossRefGoogle Scholar
  31. 31.
    Hanlon L, Cahill R, Barry MC (2006) Prospective evaluation of the efficacy of dermal botulinum toxin for primary axillary hyperhidrosis. Irish J Med Sci 175:57–58PubMedCrossRefGoogle Scholar
  32. 32.
    James R, Phillips D, Collin J (2005) Durability of botulinum toxin injection for axillary hyperhidrosis. Br J Surg 92:834–835PubMedCrossRefGoogle Scholar
  33. 33.
    Lowe PL, Cerdan-Sanz S, Lowe NJ (2003) Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments. Dermatol Surg 29:545–548PubMedCrossRefGoogle Scholar
  34. 34.
    Schnider P, Moraru E, Kittler H et al (2001) Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients. Br J Dermatol 145:289–293PubMedCrossRefGoogle Scholar
  35. 35.
    Vadoud-Seyedi J, Simonart T (2007) Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study. Br J Dermatol 156:986–989PubMedCrossRefGoogle Scholar
  36. 36.
    Talarico-Filho S, Mendonça DO, Nascimento M et al (2007) A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhydrosis. Dermatol Surg 33:S44–S50PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC and International Society of Aesthetic Plastic Surgery 2011

Authors and Affiliations

  • Melissa A. Doft
    • 1
  • Jennifer L. Kasten
    • 2
  • Jeffrey A. Ascherman
    • 1
    • 3
  1. 1.Combined Divisions of Plastic Surgery at the University Hospitals of Cornell and ColumbiaNew York-Presbyterian HospitalNew YorkUSA
  2. 2.Division of Plastic Surgery, Department of SurgeryColumbia University College of Physicians and SurgeonsNew YorkUSA
  3. 3.Columbia University Medical CenterNew YorkUSA

Personalised recommendations